JNJ-42847922

JNJ-42847922 Suppliers list
Company Name: Xi an Biohorlden Industry Trade Co Ltd
Tel: +8618829283179
Email: rock@horlden.com
Products Intro: Product Name:Seltorexant
CAS:1293281-49-8
Purity:98% Package:1g|10g Remarks:1g; 10g; 100g
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:Seltorexant
CAS:1293281-49-8
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Seltorexant
CAS:1293281-49-8
Purity:99.86% Package:1mg;31USD|2mg;44USD|5mg;72USD Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:Seltorexant
CAS:1293281-49-8
Purity:83999% Package:10kg 25kg 200 kilograms per barrel Remarks:good
Company Name: Dideu Industries Group Limited
Tel: +86-29-89586680 +86-15129568250
Email: 1059@dideu.com
Products Intro: Product Name:JNJ-42847922
CAS:1293281-49-8
Purity:0.99 Package:5KG;1KG,100G,10G

JNJ-42847922 manufacturers

  • Seltorexant
  • Seltorexant pictures
  • 2026-08-13
  • CAS:1293281-49-8
  • Min. Order: 1g
  • Purity: 98%
  • Supply Ability: 100 g
  • Seltorexant
  • Seltorexant pictures
  • $31.00
  • 2026-06-02
  • CAS:1293281-49-8
  • Purity: 99.90%
  • Supply Ability: 10g
  • Seltorexant
  • Seltorexant pictures
  • $31.00
  • 2026-06-02
  • CAS:1293281-49-8
  • Purity: 99.90%
  • Supply Ability: 10g
JNJ-42847922 Basic information
Product Name:JNJ-42847922
Synonyms:[2-(4,6-DIMETHYLPYRIMIDIN-2-YL)-1,3,3A,4,6,6A-HEXAHYDROPYRROLO[3,4-C]PYRROL-5-YL]-[2-FLUORO-6-(TRIAZOL-2-YL)PHENYL]METHANONE;JNJ-42847922;JNJ-42847922,Cid 67116280;[5-(4,6-dimethyl-pyrimidin-2-yl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone;Methanone, [5-(4,6-dimethyl-2-pyrimidinyl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl][2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl]-;Hypocretin Receptor,JNJ42847922,HCRT Receptor,Orexin Receptor (OX Receptor),Seltorexant,movement,barrier,insomnia,somnolence,eye,blood-brain,inhibit,rapid,selective,sleep,JNJ 42847922,Inhibitor;(5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone;Seltorexant, 10 mM in DMSO
CAS:1293281-49-8
MF:C21H22FN7O
MW:407.44
EINECS:
Product Categories:API
Mol File:1293281-49-8.mol
JNJ-42847922 Structure
JNJ-42847922 Chemical Properties
Boiling point 667.7±65.0 °C(Predicted)
density 1.46±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 250 mg/mL (613.59 mM)
pka6.50±0.50(Predicted)
form Solid
color White to yellow
Safety Information
MSDS Information
JNJ-42847922 Usage And Synthesis
DescriptionSeltorexant, also known as JNJ-42847922 and MIN-202, is a potent OX2R antagonist that has been shown to promote sleep in various species. JNJ-42847922 had an approximate 2-log selectivity ratio versus the human orexin-1 receptor. Ex vivo receptor binding studies demonstrated that JNJ-42847922 quickly occupied OX2R binding sites in the rat brain after oral administration and rapidly cleared from the brain. Seltorexant shows antidepressant and sleep-promoting effects in patients with major depressive disorder. JNJ-42847922 induces somnolence in healthy subjects without residual central effects.
UsesSeltorexant (JNJ-42847922) is an orally active, high-affinity, and selective orexin-2 receptor (OX2R) antagonist (pKi values of 8.0 and 8.1 for human and rat OX2R). Seltorexant (JNJ-42847922) crosses the blood-brain barrier and quickly occupies OX2R binding sites in the rat brain[1].
in vivo

Seltorexant (JNJ-42847922) (3-30 mg/kg; p.o.) dose-dependently induces and prolongs sleep in male Sprague-Dawley rats[1].
The sleep-promoting effects of Seltorexant (30 mg/kg; p.o.; per day for 7 days) are maintained upon 7-day repeated dosing in rats[1].

Animal Model:Male Sprague-Dawley rats (350-450 g)[1]
Dosage:30 mg/kg
Administration:p.o.; per day for 7 days
Result:The reduced sleep onset (non–rapid eye movement (NREM) latency) and the increased NREM sleep duration were maintained upon 7-day repeated dosing with JNJ-42847922. The prolongation of NREM sleep time was due to a significant increase in NREM bout duration throughout the treatment period assessed on D1 and D7. Rapid eye movement (REM) sleep was only marginally affected on D4 of treatment, resulting in a small but significant reduction in REM sleep latency and an increase in REM sleep duration.
IC 50human OX2R: 8.0 (pKi); rat OX2R: 8.1 (pKi)
References[1] Bonaventure P, et al. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. J Pharmacol Exp Ther. 2015 Sep;354(3):471-82. DOI:10.1124/jpet.115.225466
Tag:JNJ-42847922(1293281-49-8) Related Product Information
JNJ-40411813 JNJ-38431055 JNJ-64619178 JNJ-42847922 Methanone,[5-(4,6-dimethyl-2-pyrimidinyl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl][4-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]- Seltorexant hydrochloride